Hosted by Indy Ahluwalia · 🇺🇸 US · EN-GB · 18 episodes
Established thought leaders with verified media credentials.
"Innovation and the Future of Pharmacovigilance" is a podcast series under our Truliant Talks platform. We dive into the fascinating world of drug safety, exploring ongoing challenges, cutting-edge technology, and future predictions in pharmacovigilance. Our expert guests provide a wealth of knowledge as they discuss topics from real-world data to post-marketing surveillance, ethical considerations, and beyond. This podcast is an invaluable resource for anyone interested in understanding how innovation is shaping the future of pharmacovigilance. Each episode promises insightful discussions, stimulating ideas, and the chance to keep abreast with the latest trends and issues in the field. Join us on this journey, deciphering the complex world of pharmacovigilance in an accessible and engaging manner.
Indy Ahluwalia hosts Innovation and the Future of Pharmacovigilance, a science show with 18 episodes published.
Send us Fan Mail Unlock the potential of the future in pharmacovigilance as we chart the transformative journey of the industry in 2024 and beyond. Discover how smaller companies are spearheading innovation by filling ni
Send us Fan Mail Marie Pihl’s journey from an assistant nurse with dreams of working in a children's hospital to becoming the Director of Operations, Technology, and Analytics in Global Patient Safety at AstraZeneca is n
Send us Fan Mail What can we learn from a leader at the forefront of pharmacovigilance and risk management? Thomas Kuckuk, Head of System Operations Management at Novartis, offers an insightful journey through his career
Send us Fan Mail Sabura Matthews, a visionary in digital strategy for global patient safety, shares her transformative journey from the fast-paced world of trauma nursing to the strategic realm of pharmacovigilance. Her
Send us Fan Mail What do you get when you combine a background in neurobiology with a serendipitous introduction to pharmacovigilance? Join us as Sibel Guerler, Head of Strategy and Safety Evaluation at BMS, takes us on
Send us Fan Mail Ever wondered how a liberal arts major, MBA holder, and former infantry officer navigates the complex world of pharmacovigilance? Our special guest, Richard Wolff, Vice President of Client Relations at R
Send us Fan Mail Embark on a captivating journey with Nicole Baker, the pioneering CEO of Biologit, as she shares her remarkable transition from academia to the forefront of pharmacovigilance on Truliant Talks. Nicole's
Send us Fan Mail Embark on a transformational trek with Bill Ringbloom, AstraZeneca's Head of Global Patient Safety Technical Solutions as he shares his unconventional career trajectory from the financial chaos of 2008 t
Send us Fan Mail Embark on an enlightening expedition, as we navigate the vital intricacies of pharmacovigilance and risk management alongside Tom Nichols, zoologist turned PV aficionado and Director of Drive Phase PV. T
Send us Fan Mail Discover the intricate world of pharmacovigilance as Colleen Walsh, the Vice President of Global Patient Safety Operations at Alnylam, unveils her personal journey through the ever-evolving landscape of
Send us Fan Mail Embark on an insightful exploration of pharmacovigilance with me, Indy Ahluwalia, as I sit down with industry trailblazer Rishi Chopra on Truliant Talks. Witness the fascinating narrative of Rishi's tran
Send us Fan Mail Embark on a journey through the dynamic world of pharmacovigilance with Michael Braun-Boghos, the seasoned Senior Director of Safety Strategy at Oracle. In our first episode of the season, Michael unpack
Send us Fan Mail Prepare to have your perceptions of pharmacovigilance revolutionized as we're joined by the trailblazing co-founders of Truliant Consulting. We're peeling back the layers of AI's profound impact on the p
Send us Fan Mail Today's conversation comes alive with Tony De Sousa, the Global Head of Countries and Regions at Novartis, leading the discourse on a fascinating journey through the world of pharmacovigilance. Tony's in
Send us Fan Mail Ever wondered how a company navigates the complexities of Pharmacovigilance (PV)? Catherine Kenny, managing partner and co-founder of Signal Pharma Experts, takes us on an enlightening journey through it
Send us Fan Mail Imagine stepping into the world of pharmacovigilance with Sue Rees, founder of Sue Rees Consultancy, who has graced the industry for over three decades. As we stroll down memory lane, we relive Sue's fas
Send us Fan Mail Feeling intimidated by the thought of AI transforming the world of pharmacovigilance? Join us as we sit down with Fraser McCullum, founder of Imagine Pharmacovigilance Limited, who has spent over 20 year
Send us Fan Mail Welcome to Truliant Talks, your definitive source for the world of pharmacovigilance amd risk management. As we enter an era defined by innovation and technological advancement, Truliant Talks is proud t
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
To pitch Innovation and the Future of Pharmacovigilance, visit http://www.truliantconsulting.com for contact information, then craft a tight one-paragraph hook that ties your expertise to a gap in their recent science coverage.
Innovation and the Future of Pharmacovigilance is hosted by Indy Ahluwalia. The show is categorised under science (life) and has published 18 episodes.
Innovation and the Future of Pharmacovigilance has published 18 episodes.
Innovation and the Future of Pharmacovigilance regularly covers science, life, business. It sits in the science category, with a life focus.
Innovation and the Future of Pharmacovigilance is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Innovation and the Future of Pharmacovigilance hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Innovation and the Future of Pharmacovigilance average 49 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Innovation and the Future of Pharmacovigilance's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 3 days ago.
